LYGENT iStrab

Case Western Reserve University, $5,000

LYGENT is developing a novel, easy-to-use ophthalmic screening and diagnostic tool called the iStrab. It will afford providers with a quick, automated assessment of eye misalignment and other vision problems. The iStrab is intended to be an effective aid in clinical treatment and its simplicity and low cost should increase access to appropriate vision care for millions of children across the globe.


By continuing to use the site, you agree to the use of cookies. Read More

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.

Close